News

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...
Kidney cancer is a serious condition where kidney cells grow abnormally and form a tumour, which can spread to other body ...
In May, Klemenz participated in the Ironman 70.3 Chattanooga, which she completed, making her the first American female ...
A team of 16 staff members from the maintenance team of the enfinium Ferrybridge 2 site are set to embark on an intense ...
Among the participants in the present study, 972 developed acute kidney injury, with 411 (42.3%) unvaccinated and 467 (48%) ...
Mineralys reports Phase 2 trial success for lorundrostat, showing BP and kidney improvements in CKD patients with favorable ...
Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.
Investing.com -- Mineralys Therapeutics Inc (NASDAQ: MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and ...
They will be supported by the Oxford Kidney Unit Trust, a charity dedicated to supporting kidney patients and advancing renal and transplant research. Dr Phil Mason, chair of the Oxford Kidney Unit ...
Cauliflower brings the crunch, paired with plenty of vitamins C, B6, B9 and K, along with fiber. It also contains compounds ...
While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable ...
GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...